Literature DB >> 3675012

Sjögren's syndrome and fibrosing alveolitis complicated by pulmonary lymphoma.

R A Asherson1, F Muncey, H Pambakian, J Brostoff, G R Hughes.   

Abstract

The case of a middle aged woman who presented with fibrosing alveolitis, in her mid-forties, followed by a sicca syndrome and who subsequently developed a pulmonary lymphoma (B cell) while receiving azathioprine therapy is recorded. Of interest was the absence of polyclonal B cell activation, e.g., production of rheumatoid factor, hypergammaglobulinaemia, high titre antinuclear antibodies or antibodies to extractable nuclear antigens (ENA) during most of her illness. Persistently raised IgM levels and low IgA levels were demonstrated. The relevance of azathioprine to development of the lymphoma is discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3675012      PMCID: PMC1002236          DOI: 10.1136/ard.46.9.701

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

1.  Immunologically diagnosed malignancy in Sjögren's pseudolymphoma.

Authors:  G B Faguet; H H Webb; J F Agee; W B Ricks; A H Sharbaugh
Journal:  Am J Med       Date:  1978-09       Impact factor: 4.965

2.  Malignancy in a series of 70 patients with systemic lupus erythematosus.

Authors:  J J Canoso; A S Cohen
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

3.  Immunoregulation, oncogenic viruses, and malignant lymphomas.

Authors:  R S Schwartz
Journal:  Lancet       Date:  1972-06-10       Impact factor: 79.321

4.  Sjögren's syndrome and nodular reticulum cell sarcoma.

Authors:  J H Hornbaker; E A Foster; G S Williams; J S Davis
Journal:  Arch Intern Med       Date:  1966-11

5.  Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm.

Authors:  J Zulman; R Jaffe; N Talal
Journal:  N Engl J Med       Date:  1978-11-30       Impact factor: 91.245

6.  Increased risk of lymphoma in sicca syndrome.

Authors:  S S Kassan; T L Thomas; H M Moutsopoulos; R Hoover; R P Kimberly; D R Budman; J Costa; J L Decker; T M Chused
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

7.  Immunoblastic sarcoma with features of Sjögren's syndrome and systemic lupus erythematosus in a patient with immunoblastic lymphadenopathy.

Authors:  D A Pierce; R Stern; R Jaffe; J Zulman; N Talal
Journal:  Arthritis Rheum       Date:  1979-08

8.  [Immunoblastic lymphosarcomas. Clinicopathological aspects and course. Retrospective analysis of a series of 50 patients (author's transl)].

Authors:  B Hoerni; C Meugé; A de Mascarel; M Durand; P Richaud; G Hoerni-Simon; A Le Treut; J Chauvergne; C Lagarde
Journal:  Nouv Presse Med       Date:  1978-02-25

Review 9.  Immunoblastic sarcoma: a clinical description.

Authors:  A Lichtenstein; A M Levine; R J Lukes; A D Cramer; C R Taylor; T L Lincoln; D I Feinstein
Journal:  Cancer       Date:  1979-01       Impact factor: 6.860

10.  Systemic lupus erythematosus and lymphoma.

Authors:  J A Green; A A Dawson; W Walker
Journal:  Lancet       Date:  1978-10-07       Impact factor: 79.321

View more
  1 in total

1.  Imaging manifestations of autoimmune disease-associated lymphoproliferative disorders of the lung.

Authors:  Geewon Lee; Ho Yun Lee; Kyung Soo Lee; Kyung Jong Lee; Hoon-Suk Cha; Joungho Han; Man Pyo Chung
Journal:  Clin Rheumatol       Date:  2013-06-02       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.